BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2839658)

  • 41. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
    Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
    J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadal steroid modulation of brain opioid systems.
    Limonta P; Maggi R; Dondi D; Martini L; Piva F
    J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential regulation of preovulatory luteinizing hormone and follicle-stimulating hormone release by opioids in the proestrous rat.
    Kumru S; Simşek M; Yilmaz B; Sapmaz E; Kutlu S; Sandal S; Canpolat S
    Physiol Res; 2001; 50(4):397-403. PubMed ID: 11551146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid regulation of luteinizing hormone secretion in the male rat.
    Miller MA; Bremner WJ; Clifton DK; Dorsa DM; Steiner RA
    Biol Reprod; 1986 Aug; 35(1):17-26. PubMed ID: 3741948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of alcohol on the hypothalamic-pituitary-gonadal axis in the developing male rat.
    Little PJ; Adams ML; Cicero TJ
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1056-61. PubMed ID: 1469619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time course of effects of morphine on hypothalamic content of LHRH and serum testosterone and LH levels of morphine-tolerant and nontolerant male rats.
    Muraki T; Tokunaga Y; Matsumoto S; Makino T
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):290-5. PubMed ID: 356791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat.
    Cicero TJ; Meyer ER; Bell RD
    Life Sci; 1988; 42(18):1725-32. PubMed ID: 3283488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
    Baumann MH; Rabii J
    Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of endogenous opioid peptide inhibition of [Gln8]luteinizing hormone-releasing hormone secretion during sexual maturation in the cockerel.
    Stansfield SC; Cunningham FJ
    Endocrinology; 1988 Aug; 123(2):787-94. PubMed ID: 3293984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioidergic modulation of in vitro pulsatile gonadotropin-releasing hormone release from the isolated medial basal hypothalamus of the male guinea pig.
    Giri M; Kaufman JM
    Endocrinology; 1994 Nov; 135(5):2137-43. PubMed ID: 7956937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.
    Panerai AE; Petraglia F; Sacerdote P; Genazzani AR
    Endocrinology; 1985 Sep; 117(3):1096-9. PubMed ID: 2990867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone.
    Blank MS; Roberts DL
    Neuroendocrinology; 1982 Nov; 35(5):309-12. PubMed ID: 6755289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
    Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
    Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone ontogeny in the ovine fetus. XVIII. The effect of an opioid antagonist on luteinizing hormone secretion.
    Cuttler L; Egli CA; Styne DM; Kaplan SL; Grumbach MM
    Endocrinology; 1985 May; 116(5):1997-2002. PubMed ID: 3987627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
    Dyer RG; Mansfield S; Dean AD
    Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin inhibits naloxone-induced luteinizing hormone release in ovariectomized estrogen-primed rats.
    Akema T; Chiba A; Ikeda T; Nagami Y; Kimura F; Toyoda J
    J Neuroendocrinol; 1997 Nov; 9(11):849-57. PubMed ID: 9419836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat.
    Cicero TJ; Newman KS; Gerrity M; Schmoeker PF; Bell RD
    Life Sci; 1982 Oct; 31(15):1587-96. PubMed ID: 6755122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraventricular injection of melatonin inhibits naloxone-induced, but not NMDA- or LHRH-induced LH release in ovariectomized estrogen-primed rats.
    Akema T; Ikeda T; Chiba A; Sugiyama H; Sato I; Kimura F; Toyoda J
    Endocr J; 1999 Dec; 46(6):831-6. PubMed ID: 10724360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.